Delivery Order 36F79718D0355-36C26024F0096
Award Date
12/22/23
Potential Completion Date
12/21/24
Potential Value
$522K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Alexion Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Alexion Pharmaceuticals Inc., doing business as Alexion, for the delivery of the drug Strensiq. The award was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration and has a ceiling value of $1,253,969.76. The contract is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs GSA Schedule. Alexion has also been awarded a Blanket Purchase Agreement (BPA) by the VA National Acquisition Center for Strensiq, with a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $187,948 delivery order to Alexion Pharmaceuticals Inc., doing business as Alexion, under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. Alexion will provide the drug Strensiq to the VA to treat patients from November 3, 2023 through January 31, 2024. The contract has a firm fixed price and will be performed in Boston, Massachusetts. This delivery order...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Alexion Pharmaceuticals Inc. under the Pharmaceuticals and Drugs GSA Schedule. The $285,412.29 contract is for the provision of the drug Strensiq to treat perinatal/infantile- and juvenile-onset hypophosphatasia, a rare genetic disorder. Alexion holds a $4,239,517.80 Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for Strensiq, established...
This is a federal contract award to Alexion Pharmaceuticals Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract is a delivery order under the VA's Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule 61-IB, with a firm fixed price and a ceiling value of $291,430.80. The contract is for the supply of the drug Soliris, which is used to treat patients with perinatal/infantile- and juvenile-onset hypophosphatasia, a rare...
This is a firm fixed-price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) schedule contract, awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The award, valued at $217,000.00, is for the supply of 1,200 vials of the drug GLASSIA (alpha 1-proteinase inhibitor human, 1 gram/50 milliliters) for the VA's fiscal year 2016 requirements. The contract has a period of performance ending on September 30, 2016 and...
This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call order under Baxalta's existing GSA Schedule 61-IB contract for Pharmaceuticals and Drugs. The awarded contract has a firm-fixed price of $105,560.00 and is for the delivery of the specialty pharmaceutical drug GLASSIA (alpha 1-proteinase inhibitor). The contract has an ultimate...
This is a firm fixed-price delivery order awarded to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company, by the U.S. Department of Veterans Affairs (VA). The contract is part of the VA's Federal Supply Schedule (FSS) for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $75,295.97. The order is for pharmaceutical products, including medications like HAEGARDA, Privigen, Hizentra, and Kcentra, to support healthcare services for veterans across different VA medical...
This is a federal delivery order award to CSL Behring L.L.C., a foreign-owned for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The award, valued at $81,817.62, is for a 3-month supply of the medical product Privigen to address a shortage of the similar product Gammunex. The delivery order was issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of $201,482,280 and...
This is a federal delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company. The contract provides medications for cancer patients, with a ceiling value of $96,646.65 and an ultimate completion date of October 20, 2016. It was awarded under the VA's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of $201,482,280 and is valid through September...
This is a $101,660.40 delivery order awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company. The order was placed under CSL Behring's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The delivery order is for emergency supplies and has a completion date of September 30, 2015. CSL Behring holds additional Blanket...